CU6 ASX Chart
Snapshot
Clarity Pharmaceuticals Ltd (CU6) operates as a clinical stage radiopharmaceutical entity focused on treatment of serious diseases. The organisation develops TCTs based on the SAR Technology Platform for treatment of cancers.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | - |
| vs ASX 200 (1yr) | +9.37% |
Size
|
Market Cap
Excludes mandatory escrowed shares and foreign shares.
|
|
| ASX Rank | 406 of 2,339 |
| Sector Rank | 20 of 241 |
Announcements
Corporate Overview
Corporate Details
| Head Office | Sydney NSW 2000 |
| Website | www.claritypharmaceuticals.com |
| Registry | MUFG Corporate Markets (AU) Limited |
| Auditor | Grant Thornton Audit Pty Ltd |
| Date Listed | 25 Aug 2021 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 27/08/2026 | Report (Prelim) |
| 04/09/2026 | Report (Annual) |
| 26/02/2027 | Report (Interim) |
Former Company Names
- Clarity Pharmaceuticals Ltd has no former company names.
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
CU6 directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of CU6 directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Citicorp Nominees Pty Limited | 25/08/2025 | 22,096,014 | 5.94 |
| J P Morgan Nominees Australia Pty Limited | 25/08/2025 | 20,704,111 | 5.57 |
| HSBC Custody Nominees Pty Ltd | 25/08/2025 | 24,366,695 | 6.55 |
| Regal Funds Management Pty Ltd and its associates | 10/02/2026 | 26,461,673 | 7.11 |
| Vanguard Group | 20/03/2026 | 18,640,070 | 5.01 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 07-04-26 | Citigroup Global Markets Australia Pty Limited | 18,726,575 | -- | 5.03 |
| 20-03-26 | Vanguard Group | 18,640,070 | -- | 5.01 |
| 10-02-26 | Regal Funds Management Pty Ltd and its associates | 3,891,155 | 6.07 | 7.11 |
| 24-11-25 | JPmorgan Chase & Co. and its affiliates | 18,839,095 | -- | 5.06 |
| 11-11-25 | JPmorgan Chase & Co. and its affiliates | 19,466,169 | -- | 5.23 |
| 31-10-25 | Regal Funds Management Pty Ltd and its associates | 3,897,168 | 5.02 | 6.07 |
| 21-10-25 | State Street Corporation and subsidiaries | 18,836,926 | -- | 5.06 |
| 07-10-25 | Regal Funds Management Pty Ltd and its associates | 18,673,350 | -- | 5.02 |
| 16-09-25 | State Street Corporation and subsidiaries | 20,027,043 | -- | 5.38 |
| 10-09-25 | Citigroup Global Markets Australia Pty Limited | 20,796,725 | -- | 5.59 |
| 01-09-25 | Citigroup Global Markets Australia Pty Limited | 19,474,367 | -- | 5.24 |
| 28-08-25 | JPmorgan Chase & Co. and its affiliates | 3,757,122 | 6.83 | 7.84 |
| 05-08-25 | JPmorgan Chase & Co. and its affiliates | 46,973 | 7.84 | 6.83 |
| 25-07-25 | State Street Corporation and subsidiaries | 16,257,282 | -- | 5.03 |
| 21-07-25 | JPmorgan Chase & Co. and its affiliates | 5,784,688 | 6.09 | 7.84 |
| 01-07-25 | Alan John Taylor | 16,285,811 | -- | 5.04 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 08-04-26 | Citigroup Global Markets Australia Pty Limited | 18,726,575 | 5.03 | -- |
| 26-11-25 | JPmorgan Chase & Co. and its affiliates | 18,839,095 | 5.06 | -- |
| 19-11-25 | JPmorgan Chase & Co. and its affiliates | 19,466,169 | 5.23 | -- |
| 04-11-25 | JPmorgan Chase & Co. and its affiliates | 18,805,702 | 5.06 | -- |
| 31-10-25 | JPmorgan Chase & Co. and its affiliates | 4,168,898 | 6.18 | 5.06 |
| 22-10-25 | State Street Corporation and subsidiaries | 18,836,926 | 5.06 | -- |
| 03-10-25 | JPmorgan Chase & Co. and its affiliates | 6,185,673 | 7.84 | 6.18 |
| 19-09-25 | Citigroup Global Markets Australia Pty Limited | 20,796,725 | 5.59 | -- |
| 19-09-25 | State Street Corporation and subsidiaries | 20,027,043 | 5.38 | -- |
| 05-09-25 | Citigroup Global Markets Australia Pty Limited | 19,474,367 | 5.24 | -- |
| 01-08-25 | TM Ventures Pty Ltd | 18,788,460 | 6.13 | -- |
| 01-08-25 | Cabbit Pty Ltd | 17,911,280 | 5.85 | -- |
| 01-08-25 | Alan John Taylor | 16,285,811 | 5.04 | -- |
| 29-07-25 | State Street Corporation and subsidiaries | 16,257,282 | 5.03 | -- |
| 26-06-25 | JPmorgan Chase & Co. and its affiliates | 3,970,226 | 7.33 | 6.09 |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $2.50 | 30 June |
| 2024 | $5.42 | 28 June |
| 2023 | $0.70 | 30 June |
| 2022 | $0.51 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.